Insmed Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.7% | +4.1% | -5.3% | +0.9% | +0.7% | +14.8% | +19.1% | +6.6% | +39.2% | -9.8% | +4.9% | – | |
| – | -0.1% | +7.3% | +8.6% | +9.7% | +3.9% | +47.9% | +9.5% | -26.9% | +24.2% | +17.2% | -9.8% | – | |
| – | – | -818.8% | – | -139.8% | – | -335.0% | – | +45.7% | -370.9% | – | – | – | |
| – | -24.6% | +117.3% | +45.0% | -45.6% | +83.6% | +48.7% | -65.4% | -30.6% | +1,826.8% | -92.5% | +79.9% | – | |
| – | -74.8% | +16,279.4% | -102.3% | +14,693.9% | – | -39.0% | +183.3% | -434.6% | – | -31.8% | -90.8% | – | |
| – | – | – | – | – | – | -100.5% | +282.0% | -72.3% | +3.9% | +3.0% | +3.5% | – | |
| – | +9,768.9% | -97.5% | +25,760.1% | -49.2% | -59.9% | -81.8% | +2,858.2% | -96.1% | +1.3% | -12.8% | -7.9% | – | |
| – | – | – | +474.4% | -220.6% | – | -262.2% | – | -207.8% | – | -59.2% | -152.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.